Fang-Yuan Shi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Fang-Yuan Shi has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Ge Gao
State Key Laboratory of Gene Function and Modulation Research, School of Life Sciences, Biomedical Pioneering Innovative Center (BIOPIC) and Beijing Advanced Innovation Center for Genomics (ICG), Center for Bioinformatics (CBI), Peking University, Beijing, China
3 shared publications - Yu Liang
Human Aging Research Institute, School of Life Science, Nanchang University , Nanchang 330031 , China
3 shared publications - Yu Wang
Changping Laboratory, Yard 28, Science Park Road, Changping District, Beijing 102206, China
3 shared publications Junlei Zhou
School of Information Engineering, Ningxia University , Yinchuan, Ningxia 750021
2 shared publications- Zhenhua Yu
Ningxia University
2 shared publications - Dong Huang
Key Research Base of Humanities and Social Sciences of the Ministry Education, Center for Studies of Marine Economy and Sustainable Development, Dalian, 116029, China
1 shared publication
Latest Publications
- Open Access
- 3 August 2026
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 42 (8)
scDAU: a disentangled representation learning method for cross-modal translation in single-cell multi-omics data
Motivation: Cross-modal translation enables reconstruction of missing modalities in single-cell multi-omics data, supporting integrative analyses of cellular heterogeneity and regulatory relationships. However, existing methods often struggle to disentangle shared biological signals from modality-specific variation and to generalize across datasets. Results: We present scDAU, a deep learning framework that combines conditional diffusion-based feature regularization with multi-scale cross-modal translation networks. scDAU employs a feature decoupling strategy to separate shared semantic representations from modality-specific components, followed by U-Net-based architectures for accurate bidirectional translation between modalities. Across multiple benchmark datasets, scDAU outperforms existing methods in both within-dataset and cross-dataset settings, as well as in predicting modalities for previously unseen cell types. The framework further generalizes to transcriptome–proteome translation, demonstrating flexibility across diverse multi-omics contexts. Application to a human glioblastoma dataset showed that scDAU preserves cell-type-specific gene expression and chromatin accessibility patterns, supporting downstream analyses such as marker identification and functional enrichment. Overall, scDAU provides a robust and extensible approach for cross-modal translation. Availability: The source code of scDAU is available at https://github.com/zhyu-lab/scdau and https://doi.org/10.5281/zenodo.19303337.
- 3 August 2026
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 42 (8)
Open AccessscDAU: a disentangled representation learning method for cross-modal translation in single-cell multi-omics data
Motivation: Cross-modal translation enables reconstruction of missing modalities in single-cell multi-omics data, supporting integrative analyses of cellular heterogeneity and regulatory relationships. However, existing methods often struggle to disentangle shared biological signals from modality-specific variation and to generalize across datasets. Results: We present scDAU, a deep learning framework that combines conditional diffusion-based feature regularization with multi-scale cross-modal translation networks. scDAU employs a feature decoupling strategy to separate shared semantic representations from modality-specific components, followed by U-Net-based architectures for accurate bidirectional translation between modalities. Across multiple benchmark datasets, scDAU outperforms existing methods in both within-dataset and cross-dataset settings, as well as in predicting modalities for previously unseen cell types. The framework further generalizes to transcriptome–proteome translation, demonstrating flexibility across diverse multi-omics contexts. Application to a human glioblastoma dataset showed that scDAU preserves cell-type-specific gene expression and chromatin accessibility patterns, supporting downstream analyses such as marker identification and functional enrichment. Overall, scDAU provides a robust and extensible approach for cross-modal translation. Availability: The source code of scDAU is available at https://github.com/zhyu-lab/scdau and https://doi.org/10.5281/zenodo.19303337.
- 1 October 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Biomedical and Health Informatics
- Vol. 29 (10) , 7763-7775
scSTD: A Swin Transformer-Based Diffusion Model for Recovering scRNA-Seq Data
Dropout events and technical noise are pervasive challenges in single-cell RNA sequencing (scRNA-seq) data, often obscuring true gene expression profiles and undermining the reliability of downstream analyses. Existing imputation and denoising methods offer partial relief but frequently struggle with over-smoothing and fail to fully capture the complex heterogeneity of cellular states. To address these limitations, we introduce scSTD, a novel imputation and denoising framework that uniquely combines the Swin Transformer (SwinT) architecture with a latent diffusion model. In scSTD, a deep autoencoder first encodes each cell into a compact latent embedding, which is then modeled via a SwinT-based latent diffusion process designed to learn the rich, multimodal distribution of scRNA-seq data. This integration enables scSTD to accurately recover gene expression profiles while preserving subtle biological variation. By synthesizing realistic latent neighbors for each cell and aggregating their decoded outputs, scSTD achieves high-fidelity imputation and denoising. Comprehensive evaluations on both synthetic and real scRNA-seq datasets demonstrate that scSTD significantly outperforms existing methods in recovering true gene expression profiles and maintaining the topological integrity of cellular landscapes.
- 1 October 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Biomedical and Health Informatics
- Vol. 29 (10) , 7763-7775
scSTD: A Swin Transformer-Based Diffusion Model for Recovering scRNA-Seq Data
Dropout events and technical noise are pervasive challenges in single-cell RNA sequencing (scRNA-seq) data, often obscuring true gene expression profiles and undermining the reliability of downstream analyses. Existing imputation and denoising methods offer partial relief but frequently struggle with over-smoothing and fail to fully capture the complex heterogeneity of cellular states. To address these limitations, we introduce scSTD, a novel imputation and denoising framework that uniquely combines the Swin Transformer (SwinT) architecture with a latent diffusion model. In scSTD, a deep autoencoder first encodes each cell into a compact latent embedding, which is then modeled via a SwinT-based latent diffusion process designed to learn the rich, multimodal distribution of scRNA-seq data. This integration enables scSTD to accurately recover gene expression profiles while preserving subtle biological variation. By synthesizing realistic latent neighbors for each cell and aggregating their decoded outputs, scSTD achieves high-fidelity imputation and denoising. Comprehensive evaluations on both synthetic and real scRNA-seq datasets demonstrate that scSTD significantly outperforms existing methods in recovering true gene expression profiles and maintaining the topological integrity of cellular landscapes.
- Open Access
- 4 March 2025
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 26 (2)
MIRACN: a residual convolutional neural network for predicting cell line specific functional regulatory variants
In post-genome-wide association study era, interpretation of noncoding variants remains a significant challenge due to their complexity and the limited understanding of their functions. Here, we developed MIRACN, a novel residual convolutional neural network designed to predict cell line-specific functional regulatory variants. By utilizing a substantial dataset from massively parallel reporter assays (MPRAs) and employing a multitask learning strategy, MIRACN was trained across seven distinct cell lines, attaining superior performance compared to existing methods, especially in predicting cell type specificity. Comparative evaluations on an independent MPRA test dataset demonstrated that MIRACN not only outperformed in identifying regulatory variants but also provided valuable insights into their cellular context-specific regulatory mechanisms. MIRACN is capable of not only providing scores for functional variants but also pinpointing the specific cell line in which these variants display their function. This enhancement has improved the resolution of current research on the functionality of noncoding variants and has paved the way for more precise diagnostic and therapeutic strategies.
- 4 March 2025
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 26 (2)
Open AccessMIRACN: a residual convolutional neural network for predicting cell line specific functional regulatory variants
In post-genome-wide association study era, interpretation of noncoding variants remains a significant challenge due to their complexity and the limited understanding of their functions. Here, we developed MIRACN, a novel residual convolutional neural network designed to predict cell line-specific functional regulatory variants. By utilizing a substantial dataset from massively parallel reporter assays (MPRAs) and employing a multitask learning strategy, MIRACN was trained across seven distinct cell lines, attaining superior performance compared to existing methods, especially in predicting cell type specificity. Comparative evaluations on an independent MPRA test dataset demonstrated that MIRACN not only outperformed in identifying regulatory variants but also provided valuable insights into their cellular context-specific regulatory mechanisms. MIRACN is capable of not only providing scores for functional variants but also pinpointing the specific cell line in which these variants display their function. This enhancement has improved the resolution of current research on the functionality of noncoding variants and has paved the way for more precise diagnostic and therapeutic strategies.
- Open Access
- 7 December 2021
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
- Vol. 21 (3) , 662-673
Computational Assessment of the Expression-Modulating Potential for Non-Coding Variants
Large-scale genome-wide association studies (GWAS) and expression quantitative trait locus (eQTL) studies have identified multiple non - coding variants associated with genetic diseases by affecting gene expression. However, pinpointing causal variants effectively and efficiently remains a serious challenge. Here, we developed CARMEN, a novel algorithm to identify functional non-coding expression-modulating variants. Multiple evaluations demonstrated CARMEN’s superior performance over state-of-the-art tools. Applying CARMEN to GWAS and eQTL datasets further pinpointed several causal variants other than the reported lead single-nucleotide polymorphisms (SNPs). CARMEN scales well with the massive datasets, and is available online as a web server at http://carmen.gao-lab.org.
- 7 December 2021
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
- Vol. 21 (3) , 662-673
Open AccessComputational Assessment of the Expression-Modulating Potential for Non-Coding Variants
Large-scale genome-wide association studies (GWAS) and expression quantitative trait locus (eQTL) studies have identified multiple non - coding variants associated with genetic diseases by affecting gene expression. However, pinpointing causal variants effectively and efficiently remains a serious challenge. Here, we developed CARMEN, a novel algorithm to identify functional non-coding expression-modulating variants. Multiple evaluations demonstrated CARMEN’s superior performance over state-of-the-art tools. Applying CARMEN to GWAS and eQTL datasets further pinpointed several causal variants other than the reported lead single-nucleotide polymorphisms (SNPs). CARMEN scales well with the massive datasets, and is available online as a web server at http://carmen.gao-lab.org.
- Open Access
- 3 July 2021
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
- Vol. 19 (4) , 590-601
REVA as A Well-Curated Database for Human Expression-Modulating Variants
More than 90% of disease- and trait-associated human variants are noncoding. By systematically screening multiple large-scale studies, we compiled REVA, a manually curated database for over 11.8 million experimentally tested noncoding variants with expression-modulating potentials. We provided 2424 functional annotations that could be used to pinpoint the plausible regulatory mechanism of these variants. We further benchmarked multiple state-of-the-art computational tools and found that their limited sensitivity remains a serious challenge for effective large-scale analysis. REVA provides high-quality experimentally tested expression-modulating variants with extensive functional annotations, which will be useful for users in the noncoding variant community. REVA is freely available at http://reva.gao-lab.org.
- 3 July 2021
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
- Vol. 19 (4) , 590-601
Open AccessREVA as A Well-Curated Database for Human Expression-Modulating Variants
More than 90% of disease- and trait-associated human variants are noncoding. By systematically screening multiple large-scale studies, we compiled REVA, a manually curated database for over 11.8 million experimentally tested noncoding variants with expression-modulating potentials. We provided 2424 functional annotations that could be used to pinpoint the plausible regulatory mechanism of these variants. We further benchmarked multiple state-of-the-art computational tools and found that their limited sensitivity remains a serious challenge for effective large-scale analysis. REVA provides high-quality experimentally tested expression-modulating variants with extensive functional annotations, which will be useful for users in the noncoding variant community. REVA is freely available at http://reva.gao-lab.org.
- Open Access
REVA as a Well-curated Database for Human Expression-modulating Variants
More than 80% of disease- and trait-associated human variants are noncoding. By systematically screening multiple large-scale studies, we compiled REVA, a manually curated database for over 11.8 million experimentally tested noncoding variants with expression-modulating potentials. We provided 2424 functional annotations that could be used to pinpoint plausible regulatory mechanism of these variants. We further benchmarked multiple state-of-the-art computational tools and found their limited sensitivity remains a serious challenge for effective large-scale analysis. REVA provides high-qualify experimentally tested expression-modulating variants with extensive functional annotations, which will be useful for users in the noncoding variants community. REVA is available at http://reva.gao-lab.org .
Open AccessREVA as a Well-curated Database for Human Expression-modulating Variants
More than 80% of disease- and trait-associated human variants are noncoding. By systematically screening multiple large-scale studies, we compiled REVA, a manually curated database for over 11.8 million experimentally tested noncoding variants with expression-modulating potentials. We provided 2424 functional annotations that could be used to pinpoint plausible regulatory mechanism of these variants. We further benchmarked multiple state-of-the-art computational tools and found their limited sensitivity remains a serious challenge for effective large-scale analysis. REVA provides high-qualify experimentally tested expression-modulating variants with extensive functional annotations, which will be useful for users in the noncoding variants community. REVA is available at http://reva.gao-lab.org .